Enhanced antitumor activity by the combination of dasatinib and combretastatin A-4 in vitro and in vivo Corrigendum in /10.3892/or.2024.8783

Zhang,Chong; Zhou,Shuang-Shuang; Li,Xiang-Rong; Wang,Bao-Ming; Lin,Neng-Ming; Feng,Lin-Yi; Zhang,Da-Yong; Zhang,Li-Huang; Wang,Jun-Bo; Pan,Jian-Ping

doi:10.3892/or.2013.2405

Enhanced antitumor activity by the combination of dasatinib and combretastatin A-4 in vitro and in vivo

Corrigendum in: /10.3892/or.2024.8783

Authors:
- Chong Zhang
- Shuang-Shuang Zhou
- Xiang-Rong Li
- Bao-Ming Wang
- Neng-Ming Lin
- Lin-Yi Feng
- Da-Yong Zhang
- Li-Huang Zhang
- Jun-Bo Wang
- Jian-Ping Pan
View Affiliations

Affiliations: School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China, Laboratory of Clinical Pharmacy, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China
Published online on: April 12, 2013 https://doi.org/10.3892/or.2013.2405
Pages: 2275-2282

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study showed that the combination of dasatinib and combretastatin A-4 (CA-4) exhibited synergistic cytotoxicity in multiple types of cancer, including ovarian, hepatocellular, lung and prostate carcinoma. The enhanced apoptosis induced by dasatinib plus CA-4 was accompanied by a greater extent of mitochondrial depolarization, caspase-3 activation and PARP cleavage in HO-8910 cells. Furthermore, elevated expression of Mcl-1 led to a reduced apoptosis induced by dasatinib plus CA-4, highlighting that downregulated Mcl-1 was necessary for the potentiating effect of dasatinib to CA-4-triggered apoptosis. A clear increase in γ-H2AX expression was observed in the dasatinib + CA-4 group compared with the mono-treatment groups, indicating that dasatinib plus CA-4 may induce double-strand breaks (DSBs) in HO-8910 cells. Moreover, the increased anticancer efficacy of dasatinib combined with CA-4 was further validated in a human HO-8910 ovarian cancer xenograft model in nude mice. Our study is the first to show that the combination of dasatinib with CA-4 could be a novel and promising therapeutic approach for the treatment of cancer.

View Figures

View References

1	Jin X, Yang YD, Chen K, et al: HDMCP uncouples yeast mitochondrial respiration and alleviates steatosis in L02 and hepG2 cells by decreasing ATP and H₂O₂ levels: a novel mechanism for NAFLD. J Hepatol. 50:1019–1028. 2009. View Article : Google Scholar : PubMed/NCBI
2	Simoni D, Romagnoli R, Baruchello R, et al: Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity. J Med Chem. 51:6211–6215. 2008. View Article : Google Scholar : PubMed/NCBI
3	Tian CH, Zhao JF, Xu YP, et al: Involvement of Bombyx mori nucleopolyhedrovirus ORF41 (Bm41) in BV production and ODV envelopment. Virology. 387:184–192. 2009.PubMed/NCBI
4	Nagaiah G and Remick SC: Combretastatin A4 phosphate: a novel vascular disrupting agent. Future Oncol. 6:1219–1228. 2010. View Article : Google Scholar : PubMed/NCBI
5	Cooney MM, Radivoyevitch T, Dowlati A, et al: Cardiovascular safety profile of combretastatin a4 phosphate in a single-dose phase I study in patients with advanced cancer. Clin Cancer Res. 10:96–100. 2004. View Article : Google Scholar : PubMed/NCBI
6	Su C, He P, Yan RJ, Zhao CB and Zhang C: Study of the orientation-controlled damping temperature based on selective distribution of oligo-phenol in acrylate rubber/chlorinated butyl rubber blends. Polymer Composites. 33:860–865. 2012. View Article : Google Scholar
7	Ablikim M, Achasov MN, Alberto D, et al: Search for η_c′ decays into vector meson pairs. Physical Review D. 84:0911022011.
8	Li J, Li J, Li S, et al: Ameliorative effect of grape seed proanthocyanidin extract on thioacetamide-induced mouse hepatic fibrosis. Toxicol Lett. 213:353–360. 2012. View Article : Google Scholar : PubMed/NCBI
9	Zhang CL, Wang H and Yan J: Leptospirosis prevalence in Chinese populations in the last two decades. Microbes Infect. 14:317–323. 2012. View Article : Google Scholar : PubMed/NCBI
10	Bao YY, Xue J, Wu WJ, Wang Y, Lv ZY and Zhang CX: An immune-induced Reeler protein is involved in the Bombyx mori melanization cascade. Insect Biochem Mol Biol. 41:696–706. 2011. View Article : Google Scholar : PubMed/NCBI
11	Zhang XF, Zhang CH, Yang B, Lv N, Pan QF and Ye GX: Aggregation mechanism of Ag atoms deposited on liquid surfaces. J Phys Soc Jpn. 80:104603–104604. 2011. View Article : Google Scholar
12	Li GL, Roy B, Li XH, et al: Quantification of silkworm coactivator of MBF1 mRNA by SYBR Green I real-time RT-PCR reveals tissue- and stage-specific transcription levels. Mol Biol Rep. 36:1217–1223. 2009. View Article : Google Scholar : PubMed/NCBI
13	Zhang CQ, Liu YH, Ma XY, Feng Z and Ma ZH: Characterization of sensitivity of Rhizoctonia solani, causing rice sheath blight, to mepronil and boscalid. Crop Protection. 28:381–386. 2009.
14	Ma TY, Yan M, Zhang CS, Pei YM and Jiang CB: Stress influences on magnetization and magnetostriction in magnetically annealed Tb0.36Dy0.64(Fe0.85Co0.15)(2) polycrystals. J Appl Phys. 105:0939152009. View Article : Google Scholar
15	Dark GG, Hill SA, Prise VE, Tozer GM, Pettit GR and Chaplin DJ: Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature. Cancer Res. 57:1829–1834. 1997.PubMed/NCBI
16	Gay LJ and Felding-Habermann B: Contribution of platelets to tumour metastasis. Nat Rev Cancer. 11:123–134. 2011. View Article : Google Scholar : PubMed/NCBI
17	Assifi MM and Hines OJ: Anti-angiogenic agents in pancreatic cancer: a review. Anticancer Agents Med Chem. 11:464–469. 2011. View Article : Google Scholar : PubMed/NCBI
18	Pasquier E, Ciccolini J, Carre M, et al: Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment. Oncotarget. 2:797–809. 2011.PubMed/NCBI
19	Fang ZN, Yang B, Chen MG, Zhang CH, Xie JP and Ye GX: Growth and morphology of ultra-thin Al films on liquid substrates studied by atomic force microscopy. Thin Solid Films. 517:3408–3411. 2009. View Article : Google Scholar
20	Cao J, Xu D, Wang D, et al: ROS-driven Akt dephosphorylation at Ser-473 is involved in 4-HPR-mediated apoptosis in NB4 cells. Free Radic Biol Med. 47:536–547. 2009. View Article : Google Scholar : PubMed/NCBI
21	Liu XW, Su Y, Zhu H, et al: HIF-1α-dependent autophagy protects HeLa cells from fenretinide (4-HPR)-induced apoptosis in hypoxia. Pharmacol Res. 62:416–425. 2010.
22	Wang C, Wang JF, Chen C, et al: Learning to extract web news title in template independent way. Rough Sets and Knowledge Technology Proceedings Gold Coast. Springer; Berlin: pp. 192–199. 2009, View Article : Google Scholar
23	Chou TC and Talalay P: Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors. Eur J Biochem. 115:207–216. 1981. View Article : Google Scholar
24	Chou TC and Talalay P: Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 22:27–55. 1984. View Article : Google Scholar : PubMed/NCBI
25	Salvesen GS and Duckett CS: IAP proteins: blocking the road to death’s door. Nat Rev Mol Cell Biol. 3:401–410. 2002.
26	Zhang CL, Feng LF, Hoppe S and Hu GH: Residence time distribution: an old concept in chemical engineering and a new application in polymer processing. AIChE J. 55:279–283. 2009. View Article : Google Scholar
27	Zhang CL, Chen WQ and Yang JS: Electrically forced vibration of a rectangular piezoelectric plate of monoclinic crystals. Int J Appl Electrom Mechanics. 31:207–218. 2009.
28	Osusky KL, Hallahan DE, Fu A, Ye F, Shyr Y and Geng L: The receptor tyrosine kinase inhibitor SU11248 impedes endothelial cell migration, tubule formation, and blood vessel formation in vivo, but has little effect on existing tumor vessels. Angiogenesis. 7:225–233. 2004. View Article : Google Scholar
29	Wu D, Zhu DS, He Y, Zhang CQ and Feng L: Nondestructive detection of grey mold of eggplant based on ground multi-spectral imaging sensor. Guang Pu Xue Yu Guang Pu Fen Xi. 28:1496–1500. 2008.(In Chinese).
30	Tozer GM, Kanthou C, Lewis G, Prise VE, Vojnovic B and Hill SA: Tumour vascular disrupting agents: combating treatment resistance. Br J Radiol. 81:S12–S20. 2008. View Article : Google Scholar : PubMed/NCBI
31	Wu R, Ding W, Liu T, et al: XN05, a novel synthesized microtubule inhibitor, exhibits potent activity against human carcinoma cells in vitro. Cancer Lett. 285:13–22. 2009. View Article : Google Scholar
32	Busk M, Bohn AB, Skals M, Wang T and Horsman MR: Combretastatin-induced hypertension and the consequences for its combination with other therapies. Vascul Pharmacol. 54:13–17. 2011. View Article : Google Scholar : PubMed/NCBI
33	Zhu H, Zhang J, Xue N, Hu Y, Yang B and He Q: Novel combretastatin A-4 derivative XN0502 induces cell cycle arrest and apoptosis in A549 cells. Invest New Drugs. 28:493–501. 2010. View Article : Google Scholar : PubMed/NCBI
34	Siemann DW, Chaplin DJ and Horsman MR: Vascular-targeting therapies for treatment of malignant disease. Cancer. 100:2491–2499. 2004. View Article : Google Scholar : PubMed/NCBI
35	Narula J, Pandey P, Arbustini E, et al: Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci USA. 96:8144–8149. 1999. View Article : Google Scholar : PubMed/NCBI
36	Kashkar H: X-linked inhibitor of apoptosis: a chemoresistance factor or a hollow promise. Clin Cancer Res. 16:4496–4502. 2010. View Article : Google Scholar : PubMed/NCBI
37	Zhao GL, Li H, Zhang CS and Han GR: Preparation of TiO₂ films under low temperature condition on the glass substrate. Rare Metal Mat Eng. 37:148–150. 2008.
38	Xu HJ, Yang ZN, Zhao JF, et al: Bombyx mori nucleopolyhedrovirus ORF56 encodes an occlusion-derived virus protein and is not essential for budded virus production. J Gen Virol. 89:1212–1219. 2008. View Article : Google Scholar
39	Ablikim M, Bai JZ, Ban Y, et al: Determination of the psi (3770), psi (4040), psi (4160) and psi (4415) resonance parameters. Physics Lett B. 660:315–319. 2008. View Article : Google Scholar
40	Saxena P and Tesar PJ: Vascular obstruction related to mediastinal fibrosis: an interesting clinical entity. J Thorac Cardiovasc Surg. 134:1379–1380. 2007. View Article : Google Scholar : PubMed/NCBI
41	Kinner A, Wu W, Staudt C and Iliakis G: γ-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res. 36:5678–5694. 2008.
42	Mah LJ, El-Osta A and Karagiannis TC: γH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia. 24:679–686. 2010.
43	Smart DJ, Ahmedi KP, Harvey JS and Lynch AM: Genotoxicity screening via the γH2AX by flow assay. Mutat Res. 715:25–31. 2011.
44	Zhang DY, Pan Y, Zhang C, et al: Wnt/β-catenin signaling induces the aging of mesenchymal stem cells through promoting the ROS production. Mol Cell Biochem. 374:13–20. 2012.
45	Gartner A, Milstein S, Ahmed S, Hodgkin J and Hengartner MO: A conserved checkpoint pathway mediates DNA damage - induced apoptosis and cell cycle arrest in C. elegans. Mol Cell. 5:435–443. 2000. View Article : Google Scholar : PubMed/NCBI
46	Kawanishi S and Hiraku Y: Amplification of anticancer drug-induced DNA damage and apoptosis by DNA-binding compounds. Curr Med Chem Anticancer Agents. 4:415–419. 2004. View Article : Google Scholar : PubMed/NCBI